Release Summary

First Presentation of Efficacy Data from CheckMate -204 Evaluating the Combination of Opdivo and Yervoy Demonstrates Anti-tumor Activity in Advanced Melanoma Patients with Brain Metastases

Bristol-Myers Squibb